Therapeutic Application of Berberine: a Consolidated Review

[1]  Y. Singh,et al.  Unraveling physicochemical profiles and bioactivities of citrus peel essential oils: a comprehensive review , 2023, European Food Research and Technology.

[2]  J. Kenealey,et al.  Utilizing mixture design response surface methodology to determine effective combinations of plant derived compounds as prostate cancer treatments , 2023, Cancer Reports.

[3]  Rajeev K. Singla,et al.  Current trends in natural products for the treatment and management of dementia: Computational to clinical studies , 2023, Neuroscience & Biobehavioral Reviews.

[4]  M. Cirstoiu,et al.  Berberine—A Promising Therapeutic Approach to Polycystic Ovary Syndrome in Infertile/Pregnant Women , 2023, Life.

[5]  Bo Peng,et al.  Novel Anti-Cancer Products Targeting AMPK: Natural Herbal Medicine against Breast Cancer , 2023, Molecules.

[6]  J. Mahendra,et al.  Pharmacotherapeutic values of berberine: A Chinese herbal medicine for the human cancer management , 2023, Journal of biochemical and molecular toxicology.

[7]  Yaomin Xu,et al.  Glucose-lowering effect of berberine on type 2 diabetes: A systematic review and meta-analysis , 2022, Frontiers in Pharmacology.

[8]  Ali I. Al-Gareeb,et al.  The role of berberine in Covid-19: potential adjunct therapy , 2022, Inflammopharmacology.

[9]  D. Das,et al.  Pharmacological activities of limonin from Khasi Mandarin as therapeutic applications , 2022, Pharmacological Research - Modern Chinese Medicine.

[10]  Einar Vargas-Bello-Pérez,et al.  An insight into the potential of berberine in animal nutrition: Current knowledge and future perspectives. , 2022, Journal of animal physiology and animal nutrition.

[11]  F. Lin,et al.  Berberine Ameliorates Insulin Resistance by Inhibiting IKK/NF-κB, JNK, and IRS-1/AKT Signaling Pathway in Liver of Gestational Diabetes Mellitus Rats. , 2022, Metabolic syndrome and related disorders.

[12]  Yunjian Zhang,et al.  Anticancer Effects and Mechanisms of Berberine from Medicinal Herbs: An Update Review , 2022, Molecules.

[13]  L. Hall,et al.  Microbiome-based interventions to modulate gut ecology and the immune system , 2022, Mucosal Immunology.

[14]  Jiang-yao Ma,et al.  Exploring the synergistic and complementary effects of berberine and paeoniflorin in the treatment of type 2 diabetes mellitus by network pharmacology. , 2022, European journal of pharmacology.

[15]  J. Sharifi‐Rad,et al.  Paclitaxel: Application in Modern Oncology and Nanomedicine-Based Cancer Therapy , 2021, Oxidative medicine and cellular longevity.

[16]  A. Negi,et al.  Plant isoquinoline alkaloids: Advances in the chemistry and biology of berberine. , 2021, European journal of medicinal chemistry.

[17]  Lu-lu Ni,et al.  Berberine inhibits non‐small cell lung cancer cell growth through repressing DNA repair and replication rather than through apoptosis , 2021, Clinical and experimental pharmacology & physiology.

[18]  Shrinivas K. Patil.  A case series sharing novel experience of treating viral pandemic cases of morbid, mid aged, mild, moderate & severe grade with only Ayurvedic Medicines , 2021, Journal of Ayurveda and Integrative Medicine.

[19]  M. K. Panda,et al.  Insight from nanomaterials and nanotechnology towards COVID-19 , 2021, Sensors International.

[20]  Vineet K. Sharma,et al.  Cordyceps spp.: A Review on Its Immune-Stimulatory and Other Biological Potentials , 2021, Frontiers in Pharmacology.

[21]  Jing Li,et al.  Berberine inhibits chemotherapy-exacerbated ovarian cancer stem cell-like characteristics and metastasis through GLI1. , 2021, European journal of pharmacology.

[22]  Huan Yi,et al.  Therapeutic effect of berberine on metabolic diseases: Both pharmacological data and clinical evidence. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[23]  K. Satapathy,et al.  Potential bioactive molecules from natural products to combat against coronavirus , 2020, Advances in Traditional Medicine.

[24]  Sneha,et al.  Rapid determination and optimisation of berberine from Himalayan Berberis lycium by soxhlet apparatus using CCD-RSM and its quality control as a potential candidate for COVID-19 , 2020, Natural product research.

[25]  M. Sarma,et al.  Essential oils and their pharmacotherapeutics applications in human diseases , 2020, Advances in Traditional Medicine.

[26]  Xiaofei Huang,et al.  Berberine chloride suppresses non-small cell lung cancer by deregulating Sin3A/TOP2B pathway in vitro and in vivo , 2020, Cancer Chemotherapy and Pharmacology.

[27]  A. Warowicka,et al.  Antiviral activity of berberine , 2020, Archives of Virology.

[28]  J. Patra,et al.  Bioactive Molecules from Alpinia Qenus: A Comprehensive Review. , 2020, Current pharmaceutical biotechnology.

[29]  B. Salehi,et al.  Therapeutic Applications of Curcumin Nanomedicine Formulations in Cardiovascular Diseases , 2020, Journal of clinical medicine.

[30]  A. Atanasov,et al.  Phytochemicals for the Prevention and Treatment of Gastric Cancer: Effects and Mechanisms , 2020, International journal of molecular sciences.

[31]  K. Djafarian,et al.  Effect of Berberine on C-reactive protein: A systematic review and meta-analysis of randomized controlled trials. , 2019, Complementary therapies in medicine.

[32]  Haowen Jiang,et al.  Berberine promotes the recruitment and activation of brown adipose tissue in mice and humans , 2019, Cell Death & Disease.

[33]  H. Hosseinzadeh,et al.  Berberine and barberry (Berberis vulgaris): A clinical review , 2019, Phytotherapy research : PTR.

[34]  Chun-ching Lin,et al.  Berberine inhibits hepatitis C virus entry by targeting the viral E2 glycoprotein. , 2019, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[35]  K. Rayner,et al.  Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions. , 2018, Atherosclerosis.

[36]  A. Buzoianu,et al.  Berberine: Botanical Occurrence, Traditional Uses, Extraction Methods, and Relevance in Cardiovascular, Metabolic, Hepatic, and Renal Disorders , 2018, Front. Pharmacol..

[37]  P. Little,et al.  Flow-dependent epigenetic regulation of IGFBP5 expression by H3K27me3 contributes to endothelial anti-inflammatory effects , 2018, Theranostics.

[38]  Kavisa Ghosh,et al.  Effects of Berberine chloride on the liver of streptozotocin-induced diabetes in albino Wistar rats. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[39]  P. Little,et al.  Atheroprotective Effects and Molecular Targets of Tanshinones Derived From Herbal Medicine Danshen , 2018, Medicinal research reviews.

[40]  Yubo Xiao,et al.  Comparative effect of berberine and its derivative 8‐cetylberberine on attenuating atherosclerosis in ApoE−/− mice , 2017, International immunopharmacology.

[41]  Hailian Shi,et al.  MAPK pathways are involved in the inhibitory effect of berberine hydrochloride on gastric cancer MGC 803 cell proliferation and IL-8 secretion in vitro and in vivo. , 2016, Molecular medicine reports.

[42]  Jian-fei Long,et al.  Induced cortical neurogenesis after focal cerebral ischemia--Three active components from Huang-Lian-Jie-Du Decoction. , 2016, Journal of ethnopharmacology.

[43]  H. Huttunen,et al.  Stress-induced upregulation of VLDL receptor alters Wnt-signaling in neurons. , 2016, Experimental cell research.

[44]  X. Tong,et al.  Effect of Rhizoma coptidis (Huang Lian) on Treating Diabetes Mellitus , 2015, Evidence-based complementary and alternative medicine : eCAM.

[45]  Weijian Huang,et al.  Berberine alleviates cardiac ischemia/reperfusion injury by inhibiting excessive autophagy in cardiomyocytes. , 2015, European journal of pharmacology.

[46]  Jian-Dong Jiang,et al.  Effect of Berberine on promoting the excretion of cholesterol in high-fat diet-induced hyperlipidemic hamsters , 2015, Journal of Translational Medicine.

[47]  K. Chopra,et al.  Current knowledge and pharmacological profile of berberine: An update. , 2015, European journal of pharmacology.

[48]  Shihua Li,et al.  Therapeutic Effect of Berberine on Huntington’s Disease Transgenic Mouse Model , 2015, PloS one.

[49]  Shouwei Yue,et al.  Berberine via suppression of transient receptor potential vanilloid 4 channel improves vascular stiffness in mice , 2015, Journal of cellular and molecular medicine.

[50]  Limei Liu,et al.  Berberine improves endothelial function by inhibiting endoplasmic reticulum stress in the carotid arteries of spontaneously hypertensive rats. , 2015, Biochemical and biophysical research communications.

[51]  Yanyun Zhao,et al.  Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension. , 2015, Journal of ethnopharmacology.

[52]  E. Favari,et al.  The natural compound berberine positively affects macrophage functions involved in atherogenesis. , 2015, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[53]  Xuegang Li,et al.  The Safety and Anti-Hypercholesterolemic Effect of Coptisine in Syrian Golden Hamsters , 2015, Lipids.

[54]  Yanwen Wang,et al.  Berberine decreases cholesterol levels in rats through multiple mechanisms, including inhibition of cholesterol absorption. , 2014, Metabolism: clinical and experimental.

[55]  W. Jia,et al.  Berberine Promotes Glucose Consumption Independently of AMP-Activated Protein Kinase Activation , 2014, PloS one.

[56]  Mal-Soon Shin,et al.  Berberine prevents nigrostriatal dopaminergic neuronal loss and suppresses hippocampal apoptosis in mice with Parkinson's disease. , 2014, International journal of molecular medicine.

[57]  T. Zhao,et al.  Neurotoxic effects of berberine on long-term l-DOPA administration in 6-hydroxydopamine-lesioned rat model of Parkinson’s disease , 2013, Archives of Pharmacal Research.

[58]  I. Singh,et al.  Berberine and its derivatives: a patent review (2009 – 2012) , 2013, Expert opinion on therapeutic patents.

[59]  W. Jia,et al.  Effects and mechanisms of berberine in diabetes treatment , 2012 .

[60]  Changwei Hu,et al.  Conversion of glucose into furans in the presence of AlCl3 in an ethanol-water solvent system. , 2012, Bioresource technology.

[61]  Liang Shen,et al.  The cientificWorldJOURNAL Research Article Molecular Basis of Inhibitory Activities of Berberine against Pathogenic Enzymes in Alzheimer’s Disease , 2011 .

[62]  R. Acquaviva,et al.  Effect of berberine and Berberis aetnensis C. Presl. alkaloid extract on glutamate‐evoked tissue transglutaminase up‐regulation in astroglial cell cultures , 2011, Phytotherapy research : PTR.

[63]  Hua Zhu,et al.  Berberine-improved visceral white adipose tissue insulin resistance associated with altered sterol regulatory element-binding proteins, liver x receptors, and peroxisome proliferator-activated receptors transcriptional programs in diabetic hamsters. , 2011, Biological & pharmaceutical bulletin.

[64]  P. Libby,et al.  Progress and challenges in translating the biology of atherosclerosis , 2011, Nature.

[65]  Eliseo Guallar,et al.  Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study , 2011, European heart journal.

[66]  Myung-Koo Lee,et al.  Effects of berberine on 6-hydroxydopamine-induced neurotoxicity in PC12 cells and a rat model of Parkinson's disease , 2010, Neuroscience Letters.

[67]  L. Saccá,et al.  Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo-controlled study. , 2010, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[68]  P. R. Vuddanda,et al.  Berberine: a potential phytochemical with multispectrum therapeutic activities , 2010, Expert opinion on investigational drugs.

[69]  M. Kheir,et al.  Acute toxicity of berberine and its correlation with the blood concentration in mice. , 2010, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[70]  Yang Yang,et al.  Identification of the toxic constituents in Rhizoma Coptidis. , 2010, Journal of ethnopharmacology.

[71]  Lisa M. Miller,et al.  Berberine and plant stanols synergistically inhibit cholesterol absorption in hamsters. , 2010, Atherosclerosis.

[72]  S. Tsao,et al.  Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations. , 2009, Journal of ethnopharmacology.

[73]  Jiemei Wang,et al.  Berberine-induced decline in circulating CD31+/CD42- microparticles is associated with improvement of endothelial function in humans. , 2009, European journal of pharmacology.

[74]  N J Wald,et al.  Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies , 2009, BMJ : British Medical Journal.

[75]  Jiemei Wang,et al.  Berberine-Induced Upregulation of Circulating Endothelial Progenitor Cells Is Related to Nitric Oxide Production in Healthy Subjects , 2008, Cardiology.

[76]  A. Keech,et al.  Plasma PCSK9 concentrations correlate with LDL and total cholesterol in diabetic patients and are decreased by fenofibrate treatment. , 2008, Clinical chemistry.

[77]  D. James,et al.  Berberine and Its More Biologically Available Derivative, Dihydroberberine, Inhibit Mitochondrial Respiratory Complex I , 2008, Diabetes.

[78]  Feiqi Zhu,et al.  Berberine chloride can ameliorate the spatial memory impairment and increase the expression of interleukin-1beta and inducible nitric oxide synthase in the rat model of Alzheimer's disease , 2006, BMC Neuroscience.

[79]  Satoru Inaba,et al.  Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins , 2004, Nature Medicine.

[80]  N. Farnsworth,et al.  The value of plants used in traditional medicine for drug discovery. , 2001, Environmental health perspectives.

[81]  O. A. Cabello,et al.  Hypercholesterolemia and endothelial dysfunction. , 1995, Current opinion in lipidology.

[82]  B. Maciel,et al.  Cardiovascular effects of berberine in patients with severe congestive heart failure , 1988, Clinical cardiology.

[83]  Manasa Kumar Panda,et al.  Biosensors in diagnosing COVID-19 and recent development , 2020 .

[84]  Wei-Jia Kong,et al.  Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression. , 2009, Metabolism: clinical and experimental.

[85]  G. King,et al.  Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes , 2007, Nature Clinical Practice Endocrinology &Metabolism.